Background: Permanent hearing loss is one of the most common congenital disorders, with an estimated incidence of one to three per thousand live births far exceeding the combined incidence of conditions for which newborns are routinely screened. Objective: The aim of this study was to estimate the incidence of hearing loss in newborn at Qena University Hospital, for early diagnosis, early intervention and good prognosis. Patients and Methods: This cross-sectional study was conducted at Qena University Hospital and 100 neonates were examined. The study was conducted in a duration of 6 months. Results: There was statistically significant relationship between the presence of risk factors such as prematurity, hyperbilirubinemia, hydrocephalus, respiratory distress syndrome, and amplitude of frequencies in both ears, there was no correlation between amplitudes of frequencies in both ears and age, heart rate, respiratory rate, incubation period or temperature. Conclusion: It could be concluded that otoacoustic Emission (OAE) is a reliable test for newborn hearing screening. Although all the 200 ears passed the screening test at Qena University Hospital, this does not guarantee a low prevalence of hearing loss but due to the limited number of cases and short duration of the study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.